Phenamacril is a reversible and noncompetitive inhibitor of class I myosin.

The cyanoacrylate compound phenamacril (also known as JS399-19) is a recently identified fungicide that exerts its antifungal effect on susceptible species by inhibiting the ATPase activity of their myosin class I motor domains. Although much is known about the antifungal spectrum of phenamacril, the exact mechanism behind the phenamacril-mediated inhibition remains to be resolved. Here, we describe the characterization of the effect of phenamacril on purified myosin motor constructs from the model plant pathogen and phenamacril-susceptible species , phenamacril-resistant species, and the mycetozoan model organism Our results show that phenamacril potently (IC ∼360 nm), reversibly, and noncompetitively inhibits ATP turnover, actin binding during ATP turnover, and motor activity of myosin-1. Phenamacril also inhibits the ATPase activity of myosin-1 but has little or no inhibitory effect on the motor activity of myosin-1, human myosin-1c, and myosin isoforms 1B, 1E, and 2. Our findings indicate that phenamacril is a species-specific, noncompetitive inhibitor of class I myosin in susceptible sp.